Neuren Pharmaceuticals Limited
NURPF
$10.97
-$1.31-10.67%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 137.53M | 154.09M | 142.23M | 139.01M | 155.79M |
| Total Receivables | 108.50M | 121.56M | 9.92M | 9.70M | 9.82M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 245.70K | 275.30K | -- | -- | 2.87M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 842.90K | 944.30K | -- | -- | -- |
| Total Current Assets | 247.12M | 276.87M | 152.15M | 148.71M | 168.48M |
|
|
|||||
| Total Current Assets | 247.12M | 276.87M | 152.15M | 148.71M | 168.48M |
| Net Property, Plant & Equipment | 19.20K | 21.50K | 23.40K | 22.80K | 29.30K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.40M | 7.17M | 50.00K | 48.90K | 525.60K |
| Total Assets | 253.55M | 284.06M | 152.22M | 148.78M | 169.03M |
|
|
|||||
| Total Accounts Payable | 896.70K | 1.00M | 2.99M | 2.92M | 460.10K |
| Total Accrued Expenses | 894.90K | 1.00M | -- | -- | 1.87M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 26.53M | 29.72M | 3.00M | 2.93M | 26.82M |
| Total Other Current Liabilities | 26.53M | 29.72M | 3.00M | 2.93M | 26.82M |
| Total Current Liabilities | 28.32M | 31.73M | 5.98M | 5.85M | 29.15M |
|
|
|||||
| Total Current Liabilities | 28.32M | 31.73M | 5.98M | 5.85M | 29.15M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 25.40K | 28.40K | 19.30K | 18.90K | -- |
| Total Liabilities | 28.34M | 31.76M | 6.00M | 5.87M | 29.15M |
|
|
|||||
| Common Stock & APIC | 102.28M | 114.59M | 117.22M | 114.57M | 118.01M |
| Retained Earnings | 111.66M | 125.10M | 30.96M | 30.26M | 26.17M |
| Treasury Stock & Other | 11.26M | 12.62M | -1.97M | -1.92M | -4.30M |
| Total Common Equity | 225.20M | 252.31M | 146.22M | 142.91M | 139.88M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 225.20M | 252.31M | 146.22M | 142.91M | 139.88M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 225.20M | 252.31M | 146.22M | 142.91M | 139.88M |
|
|
|||||